A
$ Value
$5K
Shares
193
Price
$24
Filed
Jul 2
Insider
Name
Lamy Patrick
Title
Senior VP, Commercial Strategy
CIK
0001961273
Roles
Officer
Transaction Details
Transaction Date
2025-06-30
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
31,891
Footnotes
Mr. Lamy is voluntarily reporting the acquisition of these shares on June 30, 2025 pursuant to the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and Rule 16b-3(d). | In accordance with the provisions of the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan, these shares were purchased at 85% of the closing price of the Issuer's common stock on January 2, 2025.
Filing Info
Lamy Patrick's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-07-01 | AKRO | ▼ | $106K |
| 2025-06-30 | AKRO | A | $5K |
Other Insiders at AKRO (90d)
No other insider activity at this issuer in the last 90 days.